Director/PDMR Shareholding (replacement)
RNS Number : 2918Q
Nippon Active Value Fund PLC
16 October 2023
 

Nippon Active Value Fund plc (the "Company")

 

The following announcement is a replacement for the announcement released on 16/10/2023 at 11:34

under RNS No 2527Q.

 

Director/PDMR Shareholding

 

16 October 2023

 

The relevant notifications set out below are provided in accordance with the requirements of the Market Abuse Regulation.

 

Enquiries:

 

Apex Listed Companies Services (UK) Limited

020 3327 9720

Company Secretary


 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

 Noel Lamb

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-executive Director

b)

 

Initial notification /Amendment

 

 

Amendment

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Nippon Active Value Fund plc

b)

 

LEI

 

 

213800JOFEGZJYS21P75

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares

 

 



Identification code

ISIN: GB00BKLGLS10



b)

 

Nature of the transaction

 

 

Acquisition of shares pursuant to the rollover of Atlantis Japan Growth Fund into Nippon Active Value Fund

c)

 

Price(s) and volume(s)







Price(s)

Volume(s)




155.562426p. per share

11,951




155.562426p. per share

23,902







d)

 

Aggregated information




- Aggregated volume

35,853



- Price

Total price £55,773.80



e)

 

Date of the transaction

 

 

11 October 2023

f)

 

Place of the transaction

 

 

London

 

End

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAKEKFLSDFFA